GlobalRPh Renal Dosing Masterv7.4
Renal Dosing Master: fast drug lookup
Source review / handoff

Prasugrel hydrochloride (Effient), oral tablet

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

Effient - labeled renal guidance

Product / population
Prasugrel hydrochloride (Effient), oral tablet
Renal method
Renal impairment categories as defined by the cited product label
Source revision
DailyMed SPL version 2, posted Sep 09, 2022
Retrieved
2026-11-07
Local review status
Selected renal passages reviewed; independent clinician adjudication pending.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Effient - product and source limitations

Review bleeding risk, prior stroke or TIA, age and body weight independently of renal function.

What to reconcile: Apply only to the stated formulation, indication and renal population.

Selected renal passages reviewed; independent clinician adjudication pending.

Open this note and its source references
Official

Effient - labeled renal guidance

Open original reference

DailyMed / product prescribing information · Prasugrel hydrochloride (Effient), oral tablet

Renal method: Renal impairment categories as defined by the cited product label
Source date: DailyMed SPL version 2, posted Sep 09, 2022
Retrieved: 2026-11-07

Qualified no-adjustment statement. Apply only to the population, product and renal range described in this source.

Selected renal passages reviewed; independent clinician adjudication pending.

Renal guidance: 8.7 Renal Impairment

The prasugrel label specifies no renal dose reduction. ESRD experience is limited and bleeding risk in that population is increased. Review bleeding risk, prior stroke or TIA, age and body weight independently of renal function.

RDM74-effient-official-1 · Source locator: Renal guidance: 8.7 Renal Impairment

Source identity and provenance
Source family
product_label
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=69ea2d58-5353-4222-b61f-cab976fa7e5e
Retrieved
2026-11-07
Renal-function method
Renal impairment categories as defined by the cited product label
Source date/version
DailyMed SPL version 2, posted Sep 09, 2022
Hash meaning
SHA-256 of the local selected-source summary
Local summary SHA-256
2e5d0145874ea46f5bd614fa0bf310603e9d024065a04075063cb9faa2773129

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=rx-effient&s1=RDM74-effient-official&h1=f024732d578f172a416a6193d5ee4101a97bcd626f79991afab92f9d1d31c20c

Top